Baseline IFN-γ-based natural killer cell activity is associated with ex vivo expansion capacity of autologous NK cells in patients with breast cancer
Natural killer (NK) cell-based immunotherapy is increasingly explored in cancer treatment; however, inter-individual variability in NK cell expansion remains a major challenge. Clinically applicable biomarkers reflecting NK cell functional fitness prior to expansion are limited. Peripheral blood samples fr...